The following pages link to (Q4284864):
Displaying 18 items.
- A conversation with Nancy Flournoy (Q254418) (← links)
- Sequential design for binary dose-response experiments (Q301360) (← links)
- Incorporating a patient dichotomous characteristic in cancer phase I clinical trials using escalation with overdose control (Q454783) (← links)
- Design efficiency in dose finding studies (Q956828) (← links)
- Penalized optimal designs for dose-finding (Q1036729) (← links)
- Randomized group up and down experiments (Q1039833) (← links)
- Operating characteristics of the standard phase I clinical trial design. (Q1285808) (← links)
- Properties of frequency distributions induced by general ''up-and-down'' methods for estimating quantiles (Q1298913) (← links)
- Asymptotic normality of maximum likelihood estimators from multiparameter response-driven designs (Q1361748) (← links)
- Escalation with overdose control using ordinal toxicity grades for cancer phase I clinical trials (Q1929691) (← links)
- Adaptive clinical trial designs for phase I cancer studies (Q2452091) (← links)
- Cumulative cohort design for dose-finding (Q2455719) (← links)
- Optimal adaptive generalized Pólya urn design for multi-arm clinical trials (Q2482603) (← links)
- Up-and-down experiments of first and second order (Q2485984) (← links)
- Group up-and-down designs for dose-finding (Q2492509) (← links)
- An Optimizing Up-and-Down Design (Q5233891) (← links)
- Bias induced by adaptive dose-finding designs (Q5861424) (← links)
- Conditional information and inference in response-adaptive allocation designs (Q6622242) (← links)
